True however sometimes breakthrough technologies find it hard to get traction in the commercial world as they threaten existing economic entities including jobs, revenue, yields for their own investors etc etc...but as always a fan of CYP technology even before I knew it was part of a listed company. Oncology is really an awful and grizzly space and less biologically disruptive technologies should always be welcome.
Prefer to see CYP NOT bought out by the way...A CSL type price and equivalent yield (on royalties) for the next 25 years would be fine thanks.
Ann: Efficacy for CYP MSC Technology in Preclinical Asthma Study-CYP.AX, page-34
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
-0.005(2.33%) |
Mkt cap ! $37.94M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.0¢ | 21.0¢ | $423 | 2.016K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 41003 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 10656 | 1 |
View Market Depth
| Last trade - 12.11pm 27/09/2024 (20 minute delay) ? |
| CYP (ASX) Chart |